Krebs Stephanie
SEC insider (Form 3/4/5 filer). CIK 0001998150. Chief Business Officer at Sensei Biotherapeutics, Inc. (SNSE). 2 reported Form 4/5 transactions since Sep 2024; latest on Feb 14, 2025. Located in ROCKVILLE, MD.
Companies Krebs Stephanie has filed insider reports for
- Sensei Biotherapeutics, Inc. (SNSE): Officer, Chief Business Officer
Krebs Stephanie
CIK: 0001998150
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SNSE
Sensei Biotherapeutics, Inc.
Officer